J&J reportedly settles 7,500 hip-replacement lawsuits for $4B

Johnson & Johnson ($JNJ) has reportedly wrapped up thousands of lawsuits over faulty hip-replacement products with a hefty $4 billion settlement. According to Bloomberg, the deal would resolve more than 7,500 lawsuits, allocating an average of $300,000 to plaintiffs injured by failing implants. Report

Suggested Articles

If Pfizer wants Lorbrena to be a true follow-up to Xalkori, it has to win a first-line OK in ALK-positive lung cancer. And it just got closer.

Eylea sales dropped 4% to $1.11 billion amid the pandemic, but still beat expectations. And meanwhile, Regeneron's COVID antibody is advancing.

Johnson & Johnson inked a $10-per-dose vaccine supply deal with the U.S. for 100 million initial doses, with 200 million more available down the line.